Search Within

Sandra Pierina D'Angelo

Formats
  1. Meeting Abstract (136)
  2. Journal Article (104)
  3. Review (4)
  4. Research Letter (3)
  5. Book Section (1)
  6. Book Whole (1)
  7. Editorial (1)
  8. Guidelines (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (252)
  2. Hematologic Malignancies, Division of (252)
  3. Sarcoma Service (252)
  4. Solid Tumor Oncology Division (252)
  5. GSK Faculty (101)
  6. Tow Center for Developmental Oncology (TCDO) (88)

More Groups

People
  1. William Tap (104)
  2. Mark Dickson (83)
  3. Mrinal Gounder (72)
  4. Mary Keohan (70)
  5. Ping Chi (58)
  6. Cristina Antonescu (53)

More People

Years
  1. 2025 (5)
  2. 2024 (19)
  3. 2023 (20)
  4. 2022 (32)
  5. 2021 (16)
  6. 2020 (22)

More Years

Publications
  1. Journal of Clinical Oncology (101)
  2. Journal for ImmunoTherapy of Cancer (22)
  3. Annals of Oncology (16)
  4. Clinical Cancer Research (12)
  5. JAMA Oncology (5)
  6. Journal of Thoracic Oncology (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (103)
  2. Biomed Central Ltd (24)
  3. Oxford University Press (20)
  4. American Association for Cancer Research (19)
  5. Elsevier Inc. (16)
  6. Springer (9)

More Publishers

Results (252)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase Ib: Preliminary clinical activity and immune activation for NKTR-262 [TLR 7/8 agonist] plus NKTR-214 [CD122-biased agonist] in patients (pts) with locally advanced or metastatic solid tumors (REVEAL Phase Ib/II Trial)
    Meeting Abstract

    Diab, A.; Marcondes, M.; Kotzin, B.; Tagliaferri, M. A.; Hoch, U.; Li, Y.; Cattaruzza, F.; Zalevsky, J.; Brohl, A. S.; Brugarolas, J.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase I study of binimetinib (MEK162) combined with pexidartinib (PLX3397) in patients with advanced gastrointestinal stromal tumor
    Journal Article

    Rosenbaum, E.; Kelly, C.; D'Angelo, S. P.; Dickson, M. A.; Gounder, M.; Keohan, M. L.; Movva, S.; Condy, M.; Adamson, T.; Mcfadyen, C. R.; more...
    The Oncologist (2019)

    Fulltext@MSK | Save
  • Prevalence and preliminary validation of screening criteria to identify carriers of germline BAP1 mutations
    Journal Article

    Zauderer, M. G.; Jayakumaran, G.; DuBoff, M.; Zhang, L.; Francis, J. H.; Abramson, D. H.; Cercek, A.; Nash, G. M.; Shoushtari, A.; Chapman, P.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Phase I study of emactuzumab single agent or in combination with paclitaxel in patients with advanced/metastatic solid tumors reveals depletion of immunosuppressive M2-like macrophages
    Journal Article

    Gomez-Roca, C. A.; Italiano, A.; Le Tourneau, C.; Cassier, P. A.; Toulmonde, M.; D'Angelo, S. P.; Campone, M.; Weber, K. L.; Loirat, D.; Cannarile, M. A.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor
    Journal Article

    Kelly, C. M.; Shoushtari, A. N.; Qin, L. X.; D’Angelo, S. P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Mcfadyen, C.; Sjoberg, A.; Singer, S.; more...
    Investigational New Drugs (2019)

    Fulltext@MSK | Save
  • Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma
    Journal Article

    D’Angelo, S. P.; Hunger, M.; Brohl, A. S.; Nghiem, P.; Bhatia, S.; Hamid, O.; Mehnert, J. M.; Terheyden, P.; Shih, K. C.; Brownell, I.; more...
    Cancer Immunology, Immunotherapy (2019)

    Fulltext@MSK | Save
  • Tumor mutational load predicts survival after immunotherapy across multiple cancer types
    Research Letter

    Samstein, R. M.; Lee, C. H.; Shoushtari, A. N.; Hellmann, M. D.; Shen, R.; Janjigian, Y. Y.; Barron, D. A.; Zehir, A.; Jordan, E. J.; Omuro, A.; more...
    Nature Genetics (2019)

    Fulltext@MSK | Save
  • Avelumab immunotherapy: Management of adverse events associated with new treatment for Merkel cell carcinoma
    Journal Article

    Ugolini, H.; Bryan, J.; Hennessy, M.; Kaufman, H. L.; D'Angelo, S. P.
    Clinical Journal of Oncology Nursing (2019)

    Fulltext@MSK | Save
  • Langerhans-type dendritic cells electroporated with TRP-2 mRNA stimulate cellular immunity against melanoma: Results of a phase I vaccine trial
    Journal Article

    Chung, D. J.; Carvajal, R. D.; Postow, M. A.; Sharma, S.; Pronschinske, K. B.; Shyer, J. A.; Singh-Kandah, S.; Dickson, M. A.; D'Angelo, S. P.; Wolchok, J. D.; more...
    OncoImmunology (2018)

    Fulltext@MSK | Save
  • Projecting long term survival for avelumab in refractory Merkel cell carcinoma
    Meeting Abstract

    Phatak, H.; Proskorovsky, I.; Lanitis, T.; Ambavane, A.; Hunger, M.; D'Angelo, S. P.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save